BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31876369)

  • 1. SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.
    Shen Z; Li Y; Fang Y; Lin M; Feng X; Li Z; Zhan Y; Liu Y; Mou T; Lan X; Wang Y; Li G; Wang J; Deng H
    Mol Oncol; 2020 Feb; 14(2):387-406. PubMed ID: 31876369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc.
    Zhang J; Ren P; Xu D; Liu X; Liu Z; Zhang C; Li Y; Wang L; Du X; Xing B
    Cancer Lett; 2019 Jan; 440-441():106-115. PubMed ID: 30343112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis.
    Fang Y; Shen ZY; Zhan YZ; Feng XC; Chen KL; Li YS; Deng HJ; Pan SM; Wu DH; Ding Y
    Nat Commun; 2019 Sep; 10(1):3981. PubMed ID: 31484922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.
    Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M
    Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc.
    Tang J; Yan T; Bao Y; Shen C; Yu C; Zhu X; Tian X; Guo F; Liang Q; Liu Q; Zhong M; Chen J; Ge Z; Li X; Chen X; Cui Y; Chen Y; Zou W; Chen H; Hong J; Fang JY
    Nat Commun; 2019 Aug; 10(1):3499. PubMed ID: 31375671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
    Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
    Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.
    Sato K; Masuda T; Hu Q; Tobo T; Gillaspie S; Niida A; Thornton M; Kuroda Y; Eguchi H; Nakagawa T; Asano K; Mimori K
    EBioMedicine; 2019 Jun; 44():387-402. PubMed ID: 31175057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
    Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
    Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.
    Wu T; Wang G; Chen W; Zhu Z; Liu Y; Huang Z; Huang Y; Du P; Yang Y; Liu CY; Cui L
    Cell Death Dis; 2018 Feb; 9(3):315. PubMed ID: 29472532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
    Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
    Zhou S; Lu J; Li Y; Chen C; Cai Y; Tan G; Peng Z; Zhang Z; Dong Z; Kang T; Tang F
    J Exp Clin Cancer Res; 2018 Nov; 37(1):284. PubMed ID: 30477538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
    Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
    Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer.
    Liu RT; Wang GR; Liu C; Qiu J; Yan LK; Li XJ; Wang XQ
    Int J Mol Med; 2016 Sep; 38(3):703-12. PubMed ID: 27430286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.
    Zhang Z; Gao Q; Wang S
    J Cell Mol Med; 2021 Mar; 25(5):2655-2665. PubMed ID: 33533172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.